Morpheous Biotech Private Limited - Company Profile

It is a chemicals private limited company based in Noida, Uttar Pradesh, India, established in 2021.
2021 Noida, Uttar Pradesh, India Struck Off
Last Updated:
Access Report
About Morpheous Biotech Private Limited

Morpheous Biotech Private Limited, a struck off private limited company, was established on 09 February 2021 in Noida, Uttar Pradesh, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299UP2021PTC141613. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.12 M.

Its leadership includes Mukesh Kumar Srivastava (Director), Devendra Kumar Srivastav (Director), Anuja Srivastva (Director). It is based at B5-2202, Sector-16 Greater Noida ( West ), Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299UP2021PTC141613

  • Registration Number

    141613

  • Incorporation Date

    09 February 2021

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.12 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.12 M
  • Company Age 5 Year, 5 Days
Company report

Morpheous Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Morpheous Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Morpheous Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Mukesh Kumar Srivastava Director 09 Feb 2021 Current
Devendra Kumar Srivastav Director 09 Feb 2021 Current
Anuja Srivastva Director 09 Feb 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Morpheous Biotech.

Enhance accessibility to Morpheous Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Morpheous Biotech revenue growth over time
Morpheous Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Morpheous Biotech?

Unlock access to Morpheous Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Morpheous Biotech?

Unlock and access historical data on people associated with Morpheous Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Morpheous Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morpheous Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Morpheous Biotech
Recent Activity within the Organization
  • Director Appointment

    The activity Mukesh Kumar Srivastava was appointed as a Director was appointed as a Director on 09 Feb 2021 & has been associated with this company since 5 years 5 days . was completed.

  • Director Appointment

    The activity Devendra Kumar Srivastav was appointed as a Director was appointed as a Director on 09 Feb 2021 & has been associated with this company since 5 years 5 days . was completed.

  • Director Appointment

    Anuja Srivastva was appointed as a Director was appointed as a Director on 09 Feb 2021 & has been associated with this company since 5 years 5 days . was recorded as a recent event.

  • Company Incorporation

    The activity Morpheous Biotech Private Limited was registered on 09 Feb 2021 with Roc Kanpur & aged 5 years 5 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Morpheous Biotech Private Limited?

The CIN of Morpheous Biotech Private Limited is U24299UP2021PTC141613.

Where is Morpheous Biotech Private Limited headquartered?

Morpheous Biotech Private Limited is headquartered at B5-2202, Sector-16 Greater Noida ( West ), Noida, Uttar Pradesh, 201301.

When was Morpheous Biotech Private Limited incorporated?

Morpheous Biotech Private Limited was incorporated on 09 February 2021.

Who are the current directors of Morpheous Biotech Private Limited?

The current directors of Morpheous Biotech Private Limited are

What is the primary industry of Morpheous Biotech Private Limited?

The primary industry of Morpheous Biotech Private Limited is Chemicals.

Is Morpheous Biotech Private Limited a listed company?

Morpheous Biotech Private Limited is unlisted.

What is the capital structure of Morpheous Biotech Private Limited?

The authorized capital of Morpheous Biotech Private Limited is ₹1.50 M, and the paid-up capital is ₹0.12 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available